|
LANCL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.56800194629182E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.01729752294477E-11 |
| Normal-vs-Stage2 |
2.396200E-04 |
| Normal-vs-Stage3 |
2.359300E-03 |
| Normal-vs-Stage4 |
3.80770000000252E-05 |
| Stage1-vs-Stage2 |
7.706000E-01 |
| Stage1-vs-Stage3 |
2.440200E-01 |
| Stage1-vs-Stage4 |
8.629000E-01 |
| Stage2-vs-Stage3 |
5.481000E-01 |
| Stage2-vs-Stage4 |
7.108200E-01 |
| Stage3-vs-Stage4 |
4.208400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12949982700172E-10 |
| Normal-vs-AfricanAmerican |
1.49930000004073E-06 |
| Normal-vs-Asian |
3.944700E-03 |
| Caucasian-vs-AfricanAmerican |
7.929000E-01 |
| Caucasian-vs-Asian |
8.278600E-01 |
| AfricanAmerican-vs-Asian |
9.110600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.03237426887881E-12 |
| Normal-vs-Female |
2.398200E-02 |
| Male-vs-Female |
1.214300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.77569999604677E-08 |
| Normal-vs-Extreme_Weight |
2.07045491862345E-12 |
| Normal-vs-Obese |
1.67409999999313E-05 |
| Normal-vs-Extreme_Obese |
4.672100E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.485600E-01 |
| Normal_Weight-vs-Obese |
2.951800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.349600E-01 |
| Extreme_Weight-vs-Obese |
2.644000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.288800E-01 |
| Obese-vs-Extreme_Obese |
9.811400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.156820E-01 |
| Normal-vs-Age(41-60Yrs) |
1.58870000044331E-07 |
| Normal-vs-Age(61-80Yrs) |
4.68602934233786E-12 |
| Normal-vs-Age(81-100Yrs) |
3.45969999981932E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.202200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.682220E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.891800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.898200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.655000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.256200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.04249950286339E-11 |
| Normal-VS-Type2 PRCC |
2.54960053069908E-10 |
| Normal-VS-KIRP CIMP |
8.726800E-01 |
| Normal-VS-Unclassified PRCC |
4.145800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.021200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.441980E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.421600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.614500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.672300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.204600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.40300035215091E-10 |
| Normal-vs-N1 |
2.205900E-02 |
| Normal-vs-N2 |
6.096000E-03 |
| N0-vs-N1 |
1.685900E-02 |
| N0-vs-N2 |
6.666400E-01 |
| N1-vs-N2 |
4.955600E-01 |
|
|
